| |
- J.L. Conradie, L.S. Anthony, F. Azaiez, S. Baard, R.A. Bark, A.H. Barnard, J.I. Broodryk, J.C. Cornell, J.G. De Villiers, H. Du Plessis, W. Duckitt, D.T. Fourie, P.G. Gardiner, M.E. Hogan, I.H. Kohler, J. Lawrie, C. Lussi, N.R. Mantengu, R.H. McAlister, J. Mira, H.W. Mostert, C. Naidoo, F. Nemulodi, M. Sakildien, G.F. Steyn, N. Stodart, R.W. Thomae, M.J. Van Niekerk, P.A. van Schalkwyk
iThemba LABS, Somerset West, South Africa
- A. Andrighetto, A. Monetti, G.P. Prete, M. Rossignoli
INFN/LNL, Legnaro (PD), Italy
|
|
| |
iThemba LABS is a multidisciplinary research institute that provides accelerator-based facilities for physical, biomedical and material sciences, treatment of cancer patients with neutrons and protons and the production of radioisotopes and radiopharmaceuticals. The demand for beam time by the 3 main users namely, radioisotope production, nuclear physics research and medical applications, by far exceeds the available time. A feasibility study for a new radioactive ion beam and radioisotope production facility at iThemba LABS is in progress. A dedicated isotope production facility is proposed, which will free the existing K=200 separated sector cyclotron facility for nuclear physics research with stable beams. The K=200 cyclotron will be used as driver for the production of radioactive beams. An overview of the proposed facilities will be given.
|
|
